1H Magnetic Resonance Spectroscopy Assessment of the Effects of Rivastigmine on Patients with moderate Alzheimer Disease. (2025). VITAE Academia Biomédica Digital, 3(24). https://sosvitae.ucv.ve/index.php/vitae/article/view/391